CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)
Close on Nov 18, 2026Market cap $341.32MP/E –Yield –
CapsoVision revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
CapsoVision's revenue for the twelve months ending Jun 30, 2026 was $13.89M, up 11.0% year over year. For fiscal 2025 it was $13.55M, up 15.3% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.55M | +15.3% |
| FY2024 | Dec 31, 2024 | $11.76M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.64M | +9.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.79M | +0.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.92M | +13.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.54M | +19.3% |
| Q2 FY2025 | Jun 30, 2025 | $3.32M | +16.6% |
| Q1 FY2025 | Mar 31, 2025 | $2.78M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.45M | – |
| Q3 FY2024 | Sep 30, 2024 | $2.97M | – |
| Q2 FY2024 | Jun 30, 2024 | $2.84M | – |
See a number that looks wrong?